Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

HCWB

HCW Biologics Inc

Apr 18 • 12:51PM ET

1.59

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWC VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	55.52%	Shs Outstand	36.03M	Perf Week	3.25%
Market Cap	60.13M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	0.00%	Shs Float	16.82M	Perf Month	3.92%
Income	-24.99M	PEG	-	EPS next Q	-	Inst Own	2.82%	Short Float	0.09%	Perf Quarter	37.07%
Sales	2.84M	P/S	21.17	EPS this Y	18.57%	Inst Trans	14.27%	Short Ratio	0.96	Perf Half Y	-13.11%
Book/sh	0.37	P/B	4.25	EPS next Y	3.51%	ROA	-66.37%	Short Interest	0.02M	Perf Year	5.30%
Cash/sh	0.10	P/C	16.70	EPS next 5Y	-	ROE	-98.23%	52W Range	0.91 - 2.32	Perf YTD	29.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-34.57%	ROI	-126.45%	52W High	-31.47%	Beta	0.99
Dividend TTM	-	Quick Ratio	0.73	Sales past 5Y	-39.43%	Gross Margin	-20.23%	52W Low	74.73%	ATR (14)	0.15
Dividend Ex-Date	-	Current Ratio	0.73	EPS Y/Y TTM	-67.22%	Oper. Margin	-904.96%	RSI (14)	49.82	Volatility	12.03% 8.79%
Employees	45	Debt/Eq	0.48	Sales Y/Y TTM	-57.72%	Profit Margin	-879.52%	Recom	1.00	Target Price	4.00
Option/Short	No / Yes	LT Debt/Eq	0.47	EPS Q/Q	-96.36%	Payout	-	Rel Volume	0.08	Prev Close	1.59
Sales Surprise	47.11%	EPS Surprise	-106.90%	Sales Q/Q	-1.31%	Earnings	Apr 01 AMC	Avg Volume	16.61K	Price	1.59
SMA20	-4.61%	SMA50	7.93%	SMA200	-1.98%	Trades		Volume	916	Change	0.00%

Apr-01-24 10:53PM	HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -5.71%
04:10PM	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights (GlobeNewswire)
Nov-14-23 07:00AM	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire) -17.73%
Nov-08-23 07:30AM	Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting (GlobeNewswire)
Nov-01-23 07:30AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting (GlobeNewswire) -5.36%
11:00AM	Loading…
Sep-16-23 11:00AM	Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-14-23 01:27PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com) +5.45%
Sep-09-23 01:00PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-06-23 07:30AM	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 13, 2023 (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
07:00AM	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
07:14AM	Loading…
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -8.26%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.42%
06:50AM	Loading…
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research) -8.23%
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research) +6.45%
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-07-23 06:28AM	The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable (Simply Wall St.)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research) -5.22%
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) +12.75%
Jun-22-23 07:05AM	Daily Vickers Top Insider Picks for 06/22/2023 (Argus Research)
Jun-21-23 07:05AM	Daily Vickers Top Insider Picks for 06/21/2023 (Argus Research)
Jun-20-23 06:35AM	Daily Vickers Top Insider Picks for 06/20/2023 (Argus Research)
Jun-15-23 06:38AM	Daily Vickers Top Insider Picks for 06/15/2023 (Argus Research)
Jun-14-23 07:30AM	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders (GlobeNewswire)
06:39AM	Daily Vickers Top Insider Picks for 06/14/2023 (Argus Research)
Jun-13-23 06:37AM	Daily Vickers Top Insider Picks for 06/13/2023 (Argus Research)
Jun-12-23 06:47AM	Daily Vickers Top Insider Picks for 06/12/2023 (Argus Research)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research) -6.05%
May-10-23 06:13AM	HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022) (Simply Wall St.)
May-09-23 07:15AM	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire)
Apr-27-23 07:40AM	HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan (GlobeNewswire)
Apr-13-23 07:15AM	HCW Biologics Poster Presentation at AACR Annual Meeting 2023 (GlobeNewswire)
Apr-03-23 08:13AM	A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases (GlobeNewswire)
Mar-28-23 04:25PM	HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
Feb-13-23 05:21AM	Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year (Simply Wall St.)
Jan-03-23 07:50AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago (Simply Wall St.)
Dec-08-22 07:55AM	HCW Biologics Enters CRADA with National Cancer Institute (GlobeNewswire)
Dec-07-22 07:30AM	HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI Platform (GlobeNewswire)
Nov-08-22 07:00AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting (GlobeNewswire)
Nov-07-22 04:45PM	HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire)
Aug-28-22 08:06AM	Trade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Shares (Simply Wall St.)
Aug-12-22 07:00AM	HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire) +7.98%
Aug-03-22 07:15AM	U.S. Patent Issued to HCW Biologics for Foundational Platform Technology (GlobeNewswire)
Jul-27-22 07:56AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year ago (Simply Wall St.)
Jun-27-22 06:27AM	Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth (Simply Wall St.)
May-23-22 07:30AM	HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 25, 2022 (GlobeNewswire)
May-13-22 07:15AM	HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
May-05-22 07:30AM	HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI Platform At the 105th Annual Meeting of the American Association of Immunologists (GlobeNewswire)
Apr-19-22 07:33AM	HCW Biologics CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022 (GlobeNewswire)
Apr-02-22 01:10PM	Favorable turn of events for HCW Biologics Inc. (NASDAQ:HCWB) insiders who've lost US$4.2m to date on a US$6.9m purchase (Simply Wall St.)
Mar-28-22 07:00AM	HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021 (GlobeNewswire) -6.59%
Mar-24-22 08:00AM	HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest (GlobeNewswire)
Jan-24-22 09:22AM	Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers (Benzinga) +5.45%
07:00AM	Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics Novel Bifunctional Fusion Protein (GlobeNewswire)
Jan-20-22 09:24AM	HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo (Benzinga) +12.08%
08:00AM	HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens (GlobeNewswire)
Jan-19-22 08:00AM	HCW Biologics Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institutes Annual PepTalk Conference 2022 (GlobeNewswire)
Jan-18-22 06:27AM	Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-06-22 07:33AM	HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 13, 2022 (GlobeNewswire)
Dec-13-21 07:31AM	HCW Biologics Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year (GlobeNewswire)
Nov-12-21 07:00AM	HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights (GlobeNewswire)
Oct-28-21 02:45PM	Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 Results (Benzinga) +61.99%
12:13PM	Why Did HCW Biologics Shares More Than Double Today? (Benzinga)
12:06PM	48 Stocks Moving In Thursday's Mid-Day Session (Benzinga)
11:28AM	HCWB Stock: The Big FDA News That Has HCW Biologics Booming Today (InvestorPlace)
10:44AM	Mid-Morning Market Update: Markets Rise; Caterpillar Profit Beats Expectations (Benzinga)
07:00AM	HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer (GlobeNewswire)
06:16AM	HCW Biologics Stock Soars after Receiving FDA Clearance for Phase 1 Trial (Investing.com)
Oct-27-21 07:00AM	HCW Biologics Announces Appointment of Two New Members to Board of Directors (GlobeNewswire) +8.15%
Oct-20-21 07:30AM	Recent gains in HCW Biologics Inc. (NASDAQ:HCWB) help add back some value on insider purchases worth US$6.8m, still down US$4.0m (Simply Wall St.) -14.91%
Aug-31-21 09:08AM	4 Penny Stocks Insiders Are Buying (Benzinga)
Aug-25-21 09:14AM	5 Penny Stocks Insiders Are Buying (Benzinga)
Aug-24-21 07:32AM	HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic (GlobeNewswire)
Aug-17-21 07:32AM	HCW Biologics Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI) Discovery Platform (GlobeNewswire)
Aug-13-21 07:10AM	HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights (GlobeNewswire)

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rhode Peter	See Remarks	Dec 11 '23	Option Exercise	0.14	14,000	1,960	77,500	Dec 11 04:56 PM
Flowers Lee	SVP of Business Development	Dec 08 '23	Option Exercise	0.14	7,501	1,050	118,809	Dec 11 04:56 PM
Rhode Peter	See Remarks	Nov 17 '23	Option Exercise	0.14	15,000	2,100	63,500	Nov 20 04:55 PM
Byam Rebecca	Chief Financial Officer	Oct 19 '23	Option Exercise	0.14	47,249	6,615	621,195	Oct 23 04:44 PM
Wong Hing C	Chief Executive Officer	Sep 14 '23	Buy	2.08	1,800	3,741	15,314,868	Sep 18 04:36 PM
Winer Gary M	Director	Sep 14 '23	Buy	2.05	1,041	2,139	17,000	Sep 15 06:53 PM
Byam Rebecca	Chief Financial Officer	Sep 13 '23	Buy	2.10	5,000	10,490	573,946	Sep 15 06:52 PM
Winer Gary M	Director	Sep 13 '23	Buy	2.05	546	1,117	15,959	Sep 15 06:53 PM
Byam Rebecca	Chief Financial Officer	Sep 12 '23	Buy	2.09	5,000	10,442	568,946	Sep 13 05:33 PM
Winer Gary M	Director	Sep 12 '23	Buy	2.05	500	1,025	15,413	Sep 12 08:40 PM
Byam Rebecca	Chief Financial Officer	Sep 11 '23	Buy	2.05	5,000	10,273	563,946	Sep 13 05:33 PM
Winer Gary M	Director	Sep 11 '23	Buy	2.05	99	203	14,913	Sep 12 08:40 PM
Byam Rebecca	Chief Financial Officer	Sep 08 '23	Buy	2.02	5,000	10,111	558,946	Sep 08 05:25 PM
Winer Gary M	Director	Sep 08 '23	Buy	1.90	1	2	14,814	Sep 12 08:40 PM
Byam Rebecca	Chief Financial Officer	Sep 07 '23	Buy	1.95	5,000	9,742	553,946	Sep 08 05:25 PM
Winer Gary M	Director	Sep 07 '23	Buy	1.95	63	123	14,813	Sep 07 04:48 PM
Byam Rebecca	Chief Financial Officer	Sep 06 '23	Buy	1.95	5,000	9,749	548,946	Sep 07 04:47 PM
Winer Gary M	Director	Sep 05 '23	Buy	1.75	400	700	14,750	Sep 07 04:48 PM
Byam Rebecca	Chief Financial Officer	Jun 09 '23	Buy	2.06	20,000	41,286	543,946	Jun 09 06:49 PM
Flowers Lee	SVP of Business Development	Jun 08 '23	Option Exercise	0.14	5,356	750	101,308	Jun 09 08:00 PM
Flowers Lee	SVP of Business Development	Jun 08 '23	Buy	2.16	10,000	21,574	111,308	Jun 09 08:00 PM
Byam Rebecca	Chief Financial Officer	Jun 08 '23	Buy	2.21	4,696	10,388	523,946	Jun 08 07:24 PM
Byam Rebecca	Chief Financial Officer	Jun 07 '23	Buy	2.03	20,000	40,632	519,250	Jun 08 07:24 PM
Byam Rebecca	Chief Financial Officer	Jun 06 '23	Buy	1.82	19,062	34,779	499,250	Jun 07 04:46 PM
Byam Rebecca	Chief Financial Officer	Jun 05 '23	Buy	1.67	20,000	33,344	480,188	Jun 07 04:46 PM
Wong Hing C	Chief Executive Officer	Jun 02 '23	Buy	1.54	800	1,228	15,313,068	Jun 02 08:25 PM
Wong Hing C	Chief Executive Officer	Jun 01 '23	Buy	1.62	800	1,294	15,312,268	Jun 02 08:25 PM
Wong Hing C	Chief Executive Officer	May 31 '23	Buy	1.55	2,000	3,092	15,311,468	Jun 01 05:47 PM
Winer Gary M	Director	May 31 '23	Buy	1.50	500	750	14,350	Jun 01 05:29 PM
Wong Hing C	Chief Executive Officer	May 30 '23	Buy	1.55	3,000	4,658	15,309,468	Jun 01 05:47 PM
Winer Gary M	Director	May 30 '23	Buy	1.52	850	1,293	13,850	Jun 01 05:29 PM
Byam Rebecca	Chief Financial Officer	May 26 '23	Buy	1.66	20,000	33,196	460,188	May 31 05:33 PM
Byam Rebecca	Chief Financial Officer	May 25 '23	Buy	1.62	20,000	32,348	440,188	May 31 05:33 PM
Byam Rebecca	Chief Financial Officer	May 24 '23	Buy	1.61	20,000	32,150	420,188	May 24 05:25 PM
Byam Rebecca	Chief Financial Officer	May 23 '23	Buy	1.57	5,036	7,887	400,188	May 24 05:25 PM
Byam Rebecca	Chief Financial Officer	May 22 '23	Buy	1.53	33,450	51,045	395,152	May 24 05:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HCWB

HCW Biologics Inc

Upgrade your FINVIZ experience